In vivo models for preclinical testing of promising respiratory therapeutics
Respiratory diseases affect the upper respiratory tract and can result in difficulty breathing, decreased lung capacity, asthma, emphysema and a host of other conditions. Left untreated, respiratory diseases can result in chronic breathing issues and become potentially life threatening.
Eurofins recognizes the need for effective and relevant in vivo models for respiratory conditions. In order to help you bring the next potential respiratory treatment to clinical trials, we offer a number of relevant qualified models to help you understand you candidate's effectiveness.
With more than 25 years of experience, our experts can provide you the data to give you confidence to take the next step in your project.